Less Ads, More Data, More Tools Register for FREE

Renalytix secures expanded coverage in Washington, DC area

Mon, 22nd May 2023 12:18

(Sharecast News) - Kidney disease diagnostics developer Renalytix announced the expansion of insurance coverage in the US for its flagship product KidneyIntelX on Monday.

The AIM-traded firm said the expansion was secured with CareFirst BlueCross BlueShield- the largest healthcare plan in the mid-Atlantic region, serving 3.4 million members around Washington - in Maryland, the District of Columbia, and northern Virginia.

It said the partnership also included coverage for the Federal Employee Program (FEP), which is part of the Federal Employees Health Benefits (FEHB) programme administered by CareFirst.

"This agreement complements coverage already secured with Wellmark Blue Cross Blue Shield in Iowa and South Dakota - estimated 2.1 million covered lives- and BlueCross BlueShield of Illinois - estimated 8.1 million covered lives," the Renalytix board said in its statement.

At 1118 BST, shares in Renalytix were up 1.6% in London, at 88.9p.

Reporting by Josh White for Sharecast.com.

Renalytix Plc

Shares in this article

Related News

WINNERS & LOSERS: Knights profit up; GoldStone raises GBP3.5 million
6 Jul 2026

WINNERS & LOSERS: Knights profit up; GoldStone raises GBP3.5 million

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday.

WINNERS & LOSERS: Defence Holdings jumps; ADM Energy delays results
30 Jun 2026

WINNERS & LOSERS: Defence Holdings jumps; ADM Energy delays results

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.

EARNINGS AND TRADING: PensionBee sales jump 38%; Insig AI CEO invests
22 Apr 2026

EARNINGS AND TRADING: PensionBee sales jump 38%; Insig AI CEO invests

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

Corporate News Renalytix Plc + 11 more shares